Replimune Group, Inc. REPL
Set alert
19.49 USD +1.88 +10.68%
At close · Nov 2
19.51 +0.02 +0.10%
After hours · Nov 2, 4:00 PM ET
17.67 Day range 19.68
1.50 52-week range 19.68
- YTD
- +100.51%
- 1 year
- +100.31%
- Open
- 17.75
- Prev close
- 17.61
- Mkt cap
- 1.85B
- Vol
- 7.73M
- Avg vol
- 3.01M
- EPS
- -2.79
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.67
- High
- 19.68
- Forward P/E
- -29.05
- Beta
- 0.93
- Short ratio
- 11.50
- Inst. own
- 105.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2027
- 50-d avg
- 13.58
- 200-d avg
- 9.29
- 1y target
- 23.33
1M chart
Events in this range
- Oct 28, 2026Earnings: -0.54; estimate -0.784; surprise 31.12%
- Oct 29, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (9)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| RSI: Overbought | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
Discussion (20)
Sign in to join the discussion
Mark REPL 2 months ago #1IOVA is king.
Mark REPL 3 months ago #2Sold and loaded the boat with IOVA shares. Good luck.
Mark REPL 3 months ago #3Wow that was close 10000 shares sold.
Mark REPL 3 months ago #4Sold the news leaked on Reddit.
Mark REPL 3 months ago #5Volume is low.. not good..
However, if Dr. Richard Pazdur returns to lead the FDA, the impact on Iovance Biotherapeutics (IOVA) is expected to be highly favorable, particularly for its long-term oncology pipeline.
A potential return of Dr. Richard Pazdur to the FDA is widely seen as bad news for REPL because he is historically the primary reason their melanoma drug was rejected.
$REPL @TILS KILLS CANCER ?? Today is Monday, dummy
$REPL ?? Oh SHIT! ? Its gonna take off
Today the Earnings Date for $REPL ???